APO Research
Talk to an analyst

APO RESEARCH · REPORT

Automatic Insulin Dosing Device

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Automatic Insulin Dosing Device Market Outlook and Growth Opportunities 2026

4 July 2026195 pages

Choose your research edition.

Industry ResearchAutomatic Insulin Dosing Device Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Automatic Insulin Dosing Device Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Automatic Insulin Dosing Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Automatic Insulin Dosing Device Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Automatic Insulin Dosing Device Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Automatic Insulin Dosing Device market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Automatic Insulin Dosing Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Automatic Insulin Dosing Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Automatic Insulin Dosing Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Automatic Insulin Dosing Device market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Automatic Insulin Dosing Device market include Admetsys, Beta Bionics, Bigfoot Biomedical, Defymed, Dexcom, Insulet, Micro Tech Medical, Tandem Diabetes Care and Medtronic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Automatic Insulin Dosing Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Automatic Insulin Dosing Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Automatic Insulin Dosing Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Automatic Insulin Dosing Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Automatic Insulin Dosing Device Segment by Company

Admetsys

Beta Bionics

Bigfoot Biomedical

Defymed

Dexcom

Insulet

Micro Tech Medical

Tandem Diabetes Care

Medtronic

Abbott

Automatic Insulin Dosing Device Segment by Type

Threshold Suspended Device Systems

Hybrid Closed-loop APDS

Other

Automatic Insulin Dosing Device Segment by Application

Hospital

Clinic

Home Care

Others

Automatic Insulin Dosing Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Automatic Insulin Dosing Device status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Automatic Insulin Dosing Device market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Automatic Insulin Dosing Device significant trends, drivers, influence factors in global and regions.

6. To analyze Automatic Insulin Dosing Device competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Automatic Insulin Dosing Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Automatic Insulin Dosing Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Automatic Insulin Dosing Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Automatic Insulin Dosing Device market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Automatic Insulin Dosing Device industry.

Chapter 3: Detailed analysis of Automatic Insulin Dosing Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Automatic Insulin Dosing Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Automatic Insulin Dosing Device in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Automatic Insulin Dosing Device Industry Trends Table 2. Automatic Insulin Dosing Device Industry Drivers Table 3. Automatic Insulin Dosing Device Industry Opportunities and Challenges Table 4. Automatic Insulin Dosing Device Industry Restraints Table 5. Global Automatic Insulin Dosing Device Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Automatic Insulin Dosing Device Revenue Share by Company (2021-2026) Table 7. Global Automatic Insulin Dosing Device Sales Volume by Company (k units) & (2021-2026) Table 8. Global Automatic Insulin Dosing Device Sales Volume Share by Company (2021-2026) Table 9. Global Automatic Insulin Dosing Device Average Price (USD/unit) of Company (2021-2026) Table 10. Global Automatic Insulin Dosing Device Company Ranking, (2024-2026) & (USD Million) Table 11. Global Automatic Insulin Dosing Device Key Company Manufacturing Base & Headquarters Table 12. Global Automatic Insulin Dosing Device Company, Product Type & Application Table 13. Global Automatic Insulin Dosing Device Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Automatic Insulin Dosing Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Threshold Suspended Device Systems Table 18. Significant Companies of Hybrid Closed-loop APDS Table 19. Significant Companies of Other Table 20. Global Automatic Insulin Dosing Device Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Automatic Insulin Dosing Device Sales Volume by Type (2021-2026) & (k units) Table 22. Global Automatic Insulin Dosing Device Sales Volume by Type (2027-2032) & (k units) Table 23. Global Automatic Insulin Dosing Device Sales Volume Share by Type (2021-2026) Table 24. Global Automatic Insulin Dosing Device Sales Volume Share by Type (2027-2032) Table 25. Global Automatic Insulin Dosing Device Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Automatic Insulin Dosing Device Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Automatic Insulin Dosing Device Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Automatic Insulin Dosing Device Sales Value Share by Type (2021-2026) Table 29. Global Automatic Insulin Dosing Device Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinic Table 32. Significant Companies of Home Care Table 33. Significant Companies of Others Table 34. Global Automatic Insulin Dosing Device Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Automatic Insulin Dosing Device Sales Volume by Application (2021-2026) & (k units) Table 36. Global Automatic Insulin Dosing Device Sales Volume by Application (2027-2032) & (k units) Table 37. Global Automatic Insulin Dosing Device Sales Volume Share by Application (2021-2026) Table 38. Global Automatic Insulin Dosing Device Sales Volume Share by Application (2027-2032) Table 39. Global Automatic Insulin Dosing Device Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Automatic Insulin Dosing Device Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Automatic Insulin Dosing Device Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Automatic Insulin Dosing Device Sales Value Share by Application (2021-2026) Table 43. Global Automatic Insulin Dosing Device Sales Value Share by Application (2027-2032) Table 44. Global Automatic Insulin Dosing Device Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Automatic Insulin Dosing Device Sales by Region (2021-2026) & (k units) Table 46. Global Automatic Insulin Dosing Device Sales Market Share by Region (2021-2026) Table 47. Global Automatic Insulin Dosing Device Sales by Region (2027-2032) & (k units) Table 48. Global Automatic Insulin Dosing Device Sales Market Share by Region (2027-2032) Table 49. Global Automatic Insulin Dosing Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Automatic Insulin Dosing Device Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Automatic Insulin Dosing Device Sales Value Share by Region (2021-2026) Table 52. Global Automatic Insulin Dosing Device Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Automatic Insulin Dosing Device Sales Value Share by Region (2027-2032) Table 54. Global Automatic Insulin Dosing Device Market Average Price (USD/unit) by Region (2021-2026) Table 55. Global Automatic Insulin Dosing Device Market Average Price (USD/unit) by Region (2027-2032) Table 56. Global Automatic Insulin Dosing Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Automatic Insulin Dosing Device Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Automatic Insulin Dosing Device Sales by Country (2021-2026) & (k units) Table 59. Global Automatic Insulin Dosing Device Sales Market Share by Country (2021-2026) Table 60. Global Automatic Insulin Dosing Device Sales by Country (2027-2032) & (k units) Table 61. Global Automatic Insulin Dosing Device Sales Market Share by Country (2027-2032) Table 62. Global Automatic Insulin Dosing Device Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Automatic Insulin Dosing Device Sales Value Market Share by Country (2021-2026) Table 64. Global Automatic Insulin Dosing Device Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Automatic Insulin Dosing Device Sales Value Market Share by Country (2027-2032) Table 66. Admetsys Company Information Table 67. Admetsys Business Overview Table 68. Admetsys Automatic Insulin Dosing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 69. Admetsys Automatic Insulin Dosing Device Product Portfolio Table 70. Admetsys Recent Development Table 71. Beta Bionics Company Information Table 72. Beta Bionics Business Overview Table 73. Beta Bionics Automatic Insulin Dosing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Beta Bionics Automatic Insulin Dosing Device Product Portfolio Table 75. Beta Bionics Recent Development Table 76. Bigfoot Biomedical Company Information Table 77. Bigfoot Biomedical Business Overview Table 78. Bigfoot Biomedical Automatic Insulin Dosing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Bigfoot Biomedical Automatic Insulin Dosing Device Product Portfolio Table 80. Bigfoot Biomedical Recent Development Table 81. Defymed Company Information Table 82. Defymed Business Overview Table 83. Defymed Automatic Insulin Dosing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Defymed Automatic Insulin Dosing Device Product Portfolio Table 85. Defymed Recent Development Table 86. Dexcom Company Information Table 87. Dexcom Business Overview Table 88. Dexcom Automatic Insulin Dosing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Dexcom Automatic Insulin Dosing Device Product Portfolio Table 90. Dexcom Recent Development Table 91. Insulet Company Information Table 92. Insulet Business Overview Table 93. Insulet Automatic Insulin Dosing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Insulet Automatic Insulin Dosing Device Product Portfolio Table 95. Insulet Recent Development Table 96. Micro Tech Medical Company Information Table 97. Micro Tech Medical Business Overview Table 98. Micro Tech Medical Automatic Insulin Dosing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Micro Tech Medical Automatic Insulin Dosing Device Product Portfolio Table 100. Micro Tech Medical Recent Development Table 101. Tandem Diabetes Care Company Information Table 102. Tandem Diabetes Care Business Overview Table 103. Tandem Diabetes Care Automatic Insulin Dosing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Tandem Diabetes Care Automatic Insulin Dosing Device Product Portfolio Table 105. Tandem Diabetes Care Recent Development Table 106. Medtronic Company Information Table 107. Medtronic Business Overview Table 108. Medtronic Automatic Insulin Dosing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Medtronic Automatic Insulin Dosing Device Product Portfolio Table 110. Medtronic Recent Development Table 111. Abbott Company Information Table 112. Abbott Business Overview Table 113. Abbott Automatic Insulin Dosing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Abbott Automatic Insulin Dosing Device Product Portfolio Table 115. Abbott Recent Development Table 116. Key Raw Materials Table 117. Raw Materials Key Suppliers Table 118. Automatic Insulin Dosing Device Distributors List Table 119. Automatic Insulin Dosing Device Customers List Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Automatic Insulin Dosing Device Product Image Figure 2. Global Automatic Insulin Dosing Device Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Automatic Insulin Dosing Device Sales Value (2021-2032) & (US$ Million) Figure 4. Global Automatic Insulin Dosing Device Sales (2021-2032) & (k units) Figure 5. Global Automatic Insulin Dosing Device Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Automatic Insulin Dosing Device Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Threshold Suspended Device Systems Image Figure 10. Hybrid Closed-loop APDS Image Figure 11. Other Image Figure 12. Global Automatic Insulin Dosing Device Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Automatic Insulin Dosing Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Automatic Insulin Dosing Device Sales Volume Share by Type (2021-2032) Figure 15. Global Automatic Insulin Dosing Device Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Automatic Insulin Dosing Device Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Automatic Insulin Dosing Device Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Home Care Image Figure 21. Others Image Figure 22. Global Automatic Insulin Dosing Device Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Automatic Insulin Dosing Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Automatic Insulin Dosing Device Sales Volume Share by Application (2021-2032) Figure 25. Global Automatic Insulin Dosing Device Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Automatic Insulin Dosing Device Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Automatic Insulin Dosing Device Sales Value Share by Application (2021-2032) Figure 28. Global Automatic Insulin Dosing Device Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Automatic Insulin Dosing Device Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Automatic Insulin Dosing Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Automatic Insulin Dosing Device Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Automatic Insulin Dosing Device Sales Value (2021-2032) & (US$ Million) Figure 33. North America Automatic Insulin Dosing Device Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Automatic Insulin Dosing Device Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Automatic Insulin Dosing Device Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Automatic Insulin Dosing Device Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Automatic Insulin Dosing Device Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Automatic Insulin Dosing Device Sales Value (2021-2032) & (US$ Million) Figure 39. South America Automatic Insulin Dosing Device Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Automatic Insulin Dosing Device Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Automatic Insulin Dosing Device Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Automatic Insulin Dosing Device Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Automatic Insulin Dosing Device Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Threshold Suspended Device Systems
  • Hybrid Closed-loop APDS
  • Other
Applications
  • Hospital
  • Clinic
  • Home Care
  • Others
Companies covered
  • Admetsys
  • Beta Bionics
  • Bigfoot Biomedical
  • Defymed
  • Dexcom
  • Insulet
  • Micro Tech Medical
  • Tandem Diabetes Care
  • Medtronic
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Automatic Insulin Dosing Device Sales Value (2021-2032)
  4. 1.2.2 Global Automatic Insulin Dosing Device Sales Volume (2021-2032)
  5. 1.2.3 Global Automatic Insulin Dosing Device Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Automatic Insulin Dosing Device Market Dynamics
  1. 2.1 Automatic Insulin Dosing Device Industry Trends
  2. 2.2 Automatic Insulin Dosing Device Industry Drivers
  3. 2.3 Automatic Insulin Dosing Device Industry Opportunities and Challenges
  4. 2.4 Automatic Insulin Dosing Device Industry Restraints
3 Automatic Insulin Dosing Device Market by Company
  1. 3.1 Global Automatic Insulin Dosing Device Company Revenue Ranking in 2025
  2. 3.2 Global Automatic Insulin Dosing Device Revenue by Company (2021-2026)
  3. 3.3 Global Automatic Insulin Dosing Device Sales Volume by Company (2021-2026)
  4. 3.4 Global Automatic Insulin Dosing Device Average Price by Company (2021-2026)
  5. 3.5 Global Automatic Insulin Dosing Device Company Ranking (2024-2026)
  6. 3.6 Global Automatic Insulin Dosing Device Company Manufacturing Base and Headquarters
  7. 3.7 Global Automatic Insulin Dosing Device Company Product Type and Application
  8. 3.8 Global Automatic Insulin Dosing Device Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Automatic Insulin Dosing Device Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Automatic Insulin Dosing Device Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Automatic Insulin Dosing Device Market by Type
  1. 4.1 Automatic Insulin Dosing Device Type Introduction
  2. 4.1.1 Threshold Suspended Device Systems
  3. 4.1.2 Hybrid Closed-loop APDS
  4. 4.1.3 Other
  5. 4.2 Global Automatic Insulin Dosing Device Sales Volume by Type
  6. 4.2.1 Global Automatic Insulin Dosing Device Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Automatic Insulin Dosing Device Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Automatic Insulin Dosing Device Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Automatic Insulin Dosing Device Sales Value by Type
  10. 4.3.1 Global Automatic Insulin Dosing Device Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Automatic Insulin Dosing Device Sales Value by Type (2021-2032)
  12. 4.3.3 Global Automatic Insulin Dosing Device Sales Value Share by Type (2021-2032)
5 Automatic Insulin Dosing Device Market by Application
  1. 5.1 Automatic Insulin Dosing Device Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Home Care
  5. 5.1.4 Others
  6. 5.2 Global Automatic Insulin Dosing Device Sales Volume by Application
  7. 5.2.1 Global Automatic Insulin Dosing Device Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Automatic Insulin Dosing Device Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Automatic Insulin Dosing Device Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Automatic Insulin Dosing Device Sales Value by Application
  11. 5.3.1 Global Automatic Insulin Dosing Device Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Automatic Insulin Dosing Device Sales Value by Application (2021-2032)
  13. 5.3.3 Global Automatic Insulin Dosing Device Sales Value Share by Application (2021-2032)
6 Automatic Insulin Dosing Device Regional Sales and Value Analysis
  1. 6.1 Global Automatic Insulin Dosing Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Automatic Insulin Dosing Device Sales by Region (2021-2032)
  3. 6.2.1 Global Automatic Insulin Dosing Device Sales by Region: 2021-2026
  4. 6.2.2 Global Automatic Insulin Dosing Device Sales by Region (2027-2032)
  5. 6.3 Global Automatic Insulin Dosing Device Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Automatic Insulin Dosing Device Sales Value by Region (2021-2032)
  7. 6.4.1 Global Automatic Insulin Dosing Device Sales Value by Region: 2021-2026
  8. 6.4.2 Global Automatic Insulin Dosing Device Sales Value by Region (2027-2032)
  9. 6.5 Global Automatic Insulin Dosing Device Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Automatic Insulin Dosing Device Sales Value (2021-2032)
  12. 6.6.2 North America Automatic Insulin Dosing Device Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Automatic Insulin Dosing Device Sales Value (2021-2032)
  15. 6.7.2 Europe Automatic Insulin Dosing Device Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Automatic Insulin Dosing Device Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Automatic Insulin Dosing Device Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Automatic Insulin Dosing Device Sales Value (2021-2032)
  21. 6.9.2 South America Automatic Insulin Dosing Device Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Automatic Insulin Dosing Device Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Automatic Insulin Dosing Device Sales Value Share by Country, 2025 VS 2032
7 Automatic Insulin Dosing Device Country-level Sales and Value Analysis
  1. 7.1 Global Automatic Insulin Dosing Device Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Automatic Insulin Dosing Device Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Automatic Insulin Dosing Device Sales by Country (2021-2032)
  4. 7.3.1 Global Automatic Insulin Dosing Device Sales by Country (2021-2026)
  5. 7.3.2 Global Automatic Insulin Dosing Device Sales by Country (2027-2032)
  6. 7.4 Global Automatic Insulin Dosing Device Sales Value by Country (2021-2032)
  7. 7.4.1 Global Automatic Insulin Dosing Device Sales Value by Country (2021-2026)
  8. 7.4.2 Global Automatic Insulin Dosing Device Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Automatic Insulin Dosing Device Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Automatic Insulin Dosing Device Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Automatic Insulin Dosing Device Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Admetsys
  2. 8.1.1 Admetsys Company Information
  3. 8.1.2 Admetsys Business Overview
  4. 8.1.3 Admetsys Automatic Insulin Dosing Device Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Admetsys Automatic Insulin Dosing Device Product Portfolio
  6. 8.1.5 Admetsys Recent Developments
  7. 8.2 Beta Bionics
  8. 8.2.1 Beta Bionics Company Information
  9. 8.2.2 Beta Bionics Business Overview
  10. 8.2.3 Beta Bionics Automatic Insulin Dosing Device Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Beta Bionics Automatic Insulin Dosing Device Product Portfolio
  12. 8.2.5 Beta Bionics Recent Developments
  13. 8.3 Bigfoot Biomedical
  14. 8.3.1 Bigfoot Biomedical Company Information
  15. 8.3.2 Bigfoot Biomedical Business Overview
  16. 8.3.3 Bigfoot Biomedical Automatic Insulin Dosing Device Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bigfoot Biomedical Automatic Insulin Dosing Device Product Portfolio
  18. 8.3.5 Bigfoot Biomedical Recent Developments
  19. 8.4 Defymed
  20. 8.4.1 Defymed Company Information
  21. 8.4.2 Defymed Business Overview
  22. 8.4.3 Defymed Automatic Insulin Dosing Device Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Defymed Automatic Insulin Dosing Device Product Portfolio
  24. 8.4.5 Defymed Recent Developments
  25. 8.5 Dexcom
  26. 8.5.1 Dexcom Company Information
  27. 8.5.2 Dexcom Business Overview
  28. 8.5.3 Dexcom Automatic Insulin Dosing Device Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Dexcom Automatic Insulin Dosing Device Product Portfolio
  30. 8.5.5 Dexcom Recent Developments
  31. 8.6 Insulet
  32. 8.6.1 Insulet Company Information
  33. 8.6.2 Insulet Business Overview
  34. 8.6.3 Insulet Automatic Insulin Dosing Device Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Insulet Automatic Insulin Dosing Device Product Portfolio
  36. 8.6.5 Insulet Recent Developments
  37. 8.7 Micro Tech Medical
  38. 8.7.1 Micro Tech Medical Company Information
  39. 8.7.2 Micro Tech Medical Business Overview
  40. 8.7.3 Micro Tech Medical Automatic Insulin Dosing Device Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Micro Tech Medical Automatic Insulin Dosing Device Product Portfolio
  42. 8.7.5 Micro Tech Medical Recent Developments
  43. 8.8 Tandem Diabetes Care
  44. 8.8.1 Tandem Diabetes Care Company Information
  45. 8.8.2 Tandem Diabetes Care Business Overview
  46. 8.8.3 Tandem Diabetes Care Automatic Insulin Dosing Device Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Tandem Diabetes Care Automatic Insulin Dosing Device Product Portfolio
  48. 8.8.5 Tandem Diabetes Care Recent Developments
  49. 8.9 Medtronic
  50. 8.9.1 Medtronic Company Information
  51. 8.9.2 Medtronic Business Overview
  52. 8.9.3 Medtronic Automatic Insulin Dosing Device Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Medtronic Automatic Insulin Dosing Device Product Portfolio
  54. 8.9.5 Medtronic Recent Developments
  55. 8.10 Abbott
  56. 8.10.1 Abbott Company Information
  57. 8.10.2 Abbott Business Overview
  58. 8.10.3 Abbott Automatic Insulin Dosing Device Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Abbott Automatic Insulin Dosing Device Product Portfolio
  60. 8.10.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Automatic Insulin Dosing Device Value Chain Analysis
  2. 9.1.1 Automatic Insulin Dosing Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Automatic Insulin Dosing Device Sales Mode & Process
  6. 9.2 Automatic Insulin Dosing Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Automatic Insulin Dosing Device Distributors
  9. 9.2.3 Automatic Insulin Dosing Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst